Ultime notizie per 2CRSI (OTC:TCSIF) Azioni

2CRSI SA is engaged in researching, designing and manufacturing servers and IT solutions. The company offers expertise in storage solutions, intensive computing, dedicated servers, converged systems and appliances.

2CRSI SA

We are offering 2,250,000 shares of our common stock (or 2,587,500 shares if the underwriters exercise the overallotment option described below), par value $0.0001 per share (the "common stock"), at a public offering price per share of $8.00.
&nbsp;
Our common stock is listed under the symbol "BMNR" on the NYSE American.
&nbsp;
&nbsp;
The share and per share information in this prospectus, unless otherwise noted and other than in our financial statements and the notes thereto, reflect the reverse stock split of our outstanding shares of common stock at a 1-for-20 ratio pursuant to the filing of a&nbsp;Certificate of Amendment to our Amended and Restated Certificate of Incorporation on May 15, 2025.
&nbsp;

News

Offerings

BMNR

BMNR Announces Public Offering Of 2.25M Shares At $8.00 Each

<a href="https://www.businessinsider.com/amazon-freezes-hiring-budget-retail-business-this-year-2025-6" title="https://www.businessinsider.com/amazon-freezes-hiring-budget-retail-business-this-year-2025-6">https://www.businessinsider.com/amazon-freezes-hiring-budget-retail-business-this-year-2025-6</a>

Management

AMZN

'Amazon Freezes Hiring Budget For Its Big Retail Business This Year' - Business Insider Exclusive

Rubrik, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>) shares are trading on volatility Friday. The company repotted better-than-expected first-quarter financial results and issued second-quarter guidance above estimates on Thursday after the <a href="https://www.benzinga.com//node/45802271">market closed.</a>
The Details: Rubrik reported an adjusted loss of 15 cents per share, beating the consensus estimate of a 32 cent-loss. In addition, the company reported sales of $278.48 million, beating the consensus estimate of $260.35 million, and representing a 49% year-over-year growth.
Rubrik announced subscription annual reoccurring revenue grew 38% year-over-year to $1.89 billion.
The company ended the quarter with $762.1 million in cash, cash equivalents and short term investments.
Outlook: The company expects an adjusted loss per share of 33 to 35 cents for the second quarter, versus the 36-cent loss expected by analysts. Furthermore, it anticipates sales from $281 million to $283 million, versus the consensus estimate of $273.59 million.
The company now sees an adjusted loss per share from $1.02 to 96 cents for the fiscal-year, versus the consensus estimate of a $1.15 loss. It previously expected a loss between $1.23 and $1.13.
The company expects sales from $1.18 billion to $1.19 billion, versus the consensus estimate of $1.16 billion. It previously saw sales from $1.15 billion to $1.16 billion.
Analyst Changes: Following the earnings report, multiple analysts <a href="https://www.google.com/url?sa=t&amp;source=web&amp;rct=j&amp;opi=89978449&amp;url=http://www.benzinga.com/analyst-stock-ratings/price-target/25/06/45813574/these-analysts-boost-their-forecasts-on-rubrik-after-better-than-expected-q1-results&amp;ved=2ahUKEwjUobnujt2NAxVrmokEHVHfAWUQFnoECCUQAQ&amp;usg=AOvVaw0nTKSuroqaGfjZTQ8f4E2h">issued price target adjustments</a>.
<ul class="wp-block-list">
<li>Guggenheim analyst John Difucci maintained a Buy rating on Rubrik and raised the price target from&nbsp;$105&nbsp;to&nbsp;$108.</li>
<li>Truist Securities analyst Joel Fishbein maintained a Buy rating on Rubrik and raised the price target from&nbsp;$90&nbsp;to&nbsp;$110.</li>
<li>Baird analyst Shrenik Kothari maintained an Outperform rating on Rubrik and raised the price target from&nbsp;$95&nbsp;to&nbsp;$110.</li>
<li>Wells Fargo analyst Andrew Nowinski maintained an Overweight rating on Rubrik and raised the price target from&nbsp;$80&nbsp;to&nbsp;$125.</li>
<li>Cantor Fitzgerald analyst Jonathan Ruykhaver maintained an Overweight rating on Rubrik and raised the price target from&nbsp;$95&nbsp;to&nbsp;$115.</li>
</ul>
See Also: <a href="https://www.benzinga.com/markets/large-cap/25/06/45817251/rio-tinto-opens-2b-pilbara-iron-ore-mine-with-chinas-baowu">Rio Tinto Opens $2B Pilbara Iron Ore Mine With China&#8217;s Baowu</a>
RBRK Price Action: At the time of writing, Rubrik stock is trading 1.02% lower at $97.57, according to data from <a href="https://www.google.com/url?sa=t&amp;source=web&amp;rct=j&amp;opi=89978449&amp;url=https://www.benzinga.com/pro/&amp;ved=2ahUKEwjT9p_c_NyNAxWok4kEHbkOLfYQFnoECBEQAQ&amp;usg=AOvVaw0xIsPvjIcIIsWev01-6zR2">Benzinga Pro</a>.
Image: via Shutterstock

Movers

RBRK

What's Going On With Rubrik Stock Friday?

Wall Street surged into rally mode during the final trading session of the week as better-than-expected jobs data helped ease fears <a href="https://www.benzinga.com/markets/economic-data/25/06/45818251/trump-cheers-strong-jobs-data-renews-attack-on-feds-powell-rates-should-be-much-lower">of an economic slowdown.</a>
In May, nonfarm payrolls increased by 139,000—a slight dip from April's downwardly revised 147,000, but above economist forecasts of 130,000. The unemployment rate held steady at 4.2%, while wage growth beat expectations, signaling a potential<a href="https://www.benzinga.com/markets/economic-data/25/06/45812372/us-labor-markets-defies-tariff-concerns-as-nonfarm-payrolls-wages-top-expectations-in-may"> boost to consumer spending.</a>
The S&amp;P 500 rose 0.9% nearing the 6,000 mark, its highest level since Feb. 24. The Nasdaq 100 climbed 1% to over 21,720, putting tech stocks within striking distance—just 2 percentage points—of record highs.
In equities, Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) rebounded 5.6%, partially recovering from Thursday's 14% plunge triggered by a high-profile clash between Elon Musk and President Donald Trump. Cooler rhetoric on Friday helped sentiment, after the White House said no call between Trump and Musk was currently planned.
Stronger-than-expected economic data also lifted the U.S. dollar and Treasury yields, with the 10-year yield climbing 10 basis points to 4.5%.
Gold dropped 0.9% to $3,321, heading for its worst session of the week. In contrast, crude oil rallied 2.5% to nearly $65 a barrel—its highest since early April—on signs of easing geopolitical risk as Trump and Chinese President Xi Jinping agreed to meet, calming market fears of a renewed tariff war that could dent global energy demand.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) advanced 3.4% to $105,000, nearly erasing Thursday's decline.
Read also: <a href="https://www.benzinga.com/news/politics/25/06/45817556/trump-musk-feud-sends-betting-markets-into-overdrive-heres-what-traders-see-next">Trump-Musk Feud Sends Betting Markets Into Overdrive: Here&#8217;s What Traders See Next</a>
<h3 class="wp-block-heading">Friday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>Chg (%)</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,126.31</td>
<td>1.4%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,727.92</td>
<td>1.0%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,993.56</td>
<td>0.9%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,648.75</td>
<td>0.8%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12:40 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul class="wp-block-list">
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.8% to $597.90.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rose 0.8% to $427.22.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;rose 0.9% to $529.17.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) rallied 1.4% to $211.34.</li>
<li>The&nbsp;Energy&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) outperformed, up 2%; the&nbsp;Utilities&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>) lagged, down 0.1%.</li>
</ul>
<h3 class="wp-block-heading">Friday&#8217;s Stock Movers</h3>
<ul class="wp-block-list">
<li>Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) fell 4% despite slightly beating the Street&#8217;s estimates on both sales and earnings last quarter.</li>
<li>Lululemon Athletica Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) tumbled 20% as strong first-quarter results were overshadowed by a lowered full-year profit outlook, driven by rising tariff costs and increased markdowns.</li>
<li>Other stocks reacting to earnings included DocuSign, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) down 18.4%, Vail Resorts, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>) down 3.7%, Samsara Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>), down 4.9% and ABM Industries Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABM#NYSE">ABM</a>) down 14.5%. </li>
</ul>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/commodities/25/06/45819573/silver-tops-36-triggering-a-generational-technical-breakout">Silver Tops $36, Triggering A Generational Technical Breakout </a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Equities

Government

Large Cap

Macro Economic Events

Regulations

Broad U.S. Equity ETFs

Small Cap

Treasuries

Econ #s

Economics

Tech

ETFs

$BTC

AVGO

SPDR Dow Jones Industrial Average ETF Trust

DOCU

LULU

TSLA

Select Sector SPDR-Consumer Discretionary

Stocks Rally On Strong Jobs Numbers; Tesla Rebounds As Trump-Musk Feud Softens: What's Driving Markets Friday?

Raymond James analyst Sam Darkatsh maintains Toro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTC#NYSE">TTC</a>) with a Outperform and lowers the price target from $95 to $90.

Price Target

Analyst Ratings

Raymond James Maintains Outperform on Toro, Lowers Price Target to $90

Raymond James analyst Brian Peterson maintains Braze (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) with a Outperform and lowers the price target from $48 to $43.

BRZE

Raymond James Maintains Outperform on Braze, Lowers Price Target to $43

Oppenheimer analyst Ittai Kidron maintains Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) with a Outperform and raises the price target from $225 to $250.

SNOW

Oppenheimer Maintains Outperform on Snowflake, Raises Price Target to $250

Federal Reserve

Live On CNBC, Fed's Harker Says Sees Steadiness In 'Solid' Latest Job Data; Much Of Tariff Impacts Yet To Be Felt; Fed Interest Rate Policy Is Modestly Restrictive; Now Is Time For Fed To Hold Steady And Watch Data

Oppenheimer analyst Ittai Kidron maintains Zscaler (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) with a Outperform and raises the price target from $290 to $345.

Oppenheimer Maintains Outperform on Zscaler, Raises Price Target to $345

Trading Ideas

BRLS

Borealis Foods Shares Halted On Circuit Breaker To The Downside, Stock Now Up 80%

WIIM

CYCU

Cycurion shares are trading lower after the company reported a Q1 EPS miss.

Oppenheimer analyst Leland Gershell initiates coverage on Climb Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLYM#NASDAQ">CLYM</a>) with a Outperform rating and announces Price Target of $10.

Initiation

CLYM

Oppenheimer Initiates Coverage On Climb Bio with Outperform Rating, Announces Price Target of $10

Insider Trades

Abacus Global Management Form4 Filing Shows President Kevin Scott Kirby Bought 86,207 Shares At An Average Price Of $5.77/Share; President Sean McNealy Bought 86,207 Shares At An Average Price Of $5.77/Share

Oppenheimer analyst Brian Schwartz maintains Braze (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) with a Outperform and lowers the price target from $51 to $44.

Oppenheimer Maintains Outperform on Braze, Lowers Price Target to $44

NVNO

enVVeno Medical shares are trading higher after the company announced its interim two-year follow-up data on the VenoValve trial.

Abacus Global Management Form4 Filing Shows CFO William Hugh McCauley Bought 33,000 Shares At An Average Price Of $5.82/Share

JPMorgan analyst Doug Anmuth reiterated the Overweight rating on Chewy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>),<a href="https://www.benzinga.com/quote/CHWY/analyst-ratings" target="_blank" rel="noreferrer noopener"> with a price target of $36.</a>
The company will report fiscal first quarter 2025 financial results before the market <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45316009/chewy-announces-fiscal-first-quarter-2025-financial-results-conference-call" rel="noreferrer noopener">opens on Wednesday, June 11.</a>
According to Anmuth, investors are anticipating an upside to Chewy's Q1 net sales guidance of $3.06 billion–$3.09 billion and see the company raising its FY25 outlook for net sales of $12.30 billion–$12.45 billion and adjusted EBITDA margins of 5.4%–5.7%.
Anmuth maintains a bullish view on Chewy, citing its category leadership, rising profitability, and push to diversify revenue through high-margin segments like pharmacy (now at $1 billion TTM), international expansion, and Sponsored Ads.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45630622/chwy-stock-short-interest-contrarian-trade" rel="noreferrer noopener">Options Corner: A Contrarian Case Builds As Traders Short Chewy Ahead Of Earnings</a>
He notes Chewy is seen as a defensive name, with over 80% of sales coming from Autoship customers, which he sees as a major edge supporting revenue visibility and strong unit economics.
He forecasts net customer adds of 104K sequentially in the first quarter of FY25 and 421K year over year for the full year.
SimilarWeb shows the company&#8217;s web traffic rose 4% year over year in the first quarter (down from 13% in the fourth quarter), with a pickup in May, while Bloomberg points to improving trends into the second quarter.
He estimates 6% year-over-year net sales growth for the first quarter and 3% for FY25—figures he considers may be conservative.
Anmuth sees profitability supported by ads, mix, automation, scale, and cost control, projecting a 5.4% adjusted EBITDA margin (+59bps year over year) and $524M in FCF (+16% year over year).
Price Action: CHWY shares are trading higher by 1.5% to $48.19 at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/06/45818750/docusign-posts-beat-and-raise-quarter-stock-tanks-almost-20" target="_blank" rel="noreferrer noopener">DocuSign Posts Beat-And-Raise Quarter; Stock Tanks Almost 20%</a></li>
</ul>
Photo: Briana Hunter/Shutterstock

Markets

General

CHWY

Chewy's Loyalty Engine, $1B Pharmacy Business Have JPMorgan Staying Bullish Before Q1

iPower shares are trading higher after the company announced the formation of United Package NV LLC.

<h3>Gainers</h3>
<ul>
<li>Chegg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) stock moved upwards by 44.6% to $1.75 during Friday's regular session. The market value of their outstanding shares is at $186.4 million. </li>
<li>Rent the Runway (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RENT#NASDAQ">RENT</a>) stock moved upwards by 31.23% to $8.85. The market value of their outstanding shares is at $35.5 million. The company's, Q1 earnings came out yesterday. </li>
<li>iRobot (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRBT#NASDAQ">IRBT</a>) shares moved upwards by 16.56% to $3.9. The company's market cap stands at $119.6 million. </li>
<li>GoPro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GPRO#NASDAQ">GPRO</a>) shares moved upwards by 15.87% to $0.8. The market value of their outstanding shares is at $125.2 million. </li>
<li>QuantaSing Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSG#NASDAQ">QSG</a>) stock rose 15.74% to $6.47. The company's market cap stands at $330.7 million. The company's, Q3 earnings came out today. </li>
<li>Red Robin Gourmet Burgers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRGB#NASDAQ">RRGB</a>) shares increased by 15.15% to $6.99. The market value of their outstanding shares is at $123.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>YSX Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YSXT#NASDAQ">YSXT</a>) stock fell 29.1% to $5.0 during Friday's regular session. The market value of their outstanding shares is at $117.1 million. </li>
<li>Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) shares fell 24.89% to $2.72. The company's market cap stands at $758.5 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Jiade (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JDZG#NASDAQ">JDZG</a>) shares fell 22.13% to $0.27. The market value of their outstanding shares is at $6.5 million. </li>
<li>Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) stock declined by 20.18% to $264.05. The company's market cap stands at $33.0 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>G-III Apparel Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIII#NASDAQ">GIII</a>) shares fell 15.08% to $23.5. The market value of their outstanding shares is at $1.0 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Mullen Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) shares decreased by 13.32% to $7.03. The market value of their outstanding shares is at $3.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CHGG

GIII

GPRO

IRBT

JDZG

MULN

RENT

RRGB

WOOF

YSXT

12 Consumer Discretionary Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Phathom Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAT#NASDAQ">PHAT</a>) stock rose 85.8% to $8.71 during Friday's regular session. The company's market cap stands at $606.9 million. </li>
<li>Know Labs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KNW#AMEX">KNW</a>) shares rose 54.86% to $0.79. The market value of their outstanding shares is at $5.9 million. </li>
<li>Bluejay Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJDX#NASDAQ">BJDX</a>) shares rose 48.68% to $2.26. The market value of their outstanding shares is at $3.3 million. </li>
<li>China SXT Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) stock moved upwards by 39.16% to $1.86. The company's market cap stands at $48.5 million. </li>
<li>BioSig Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) stock moved upwards by 38.76% to $7.96. The market value of their outstanding shares is at $217.4 million. </li>
<li>NuCana (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNA#NASDAQ">NCNA</a>) stock moved upwards by 29.87% to $0.05. As per the news, the Q1 earnings report came out 4 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Vera Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERA#NASDAQ">VERA</a>) shares fell 29.0% to $21.74 during Friday's regular session. The market value of their outstanding shares is at $1.3 billion. </li>
<li>Scinai Immunotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNI#NASDAQ">SCNI</a>) stock fell 24.62% to $2.45. The market value of their outstanding shares is at $2.2 million. </li>
<li>Accuray (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARAY#NASDAQ">ARAY</a>) shares declined by 15.17% to $1.29. The market value of their outstanding shares is at $132.8 million. </li>
<li>Cyclacel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) shares decreased by 15.1% to $0.51. The company's market cap stands at $12.2 million. </li>
<li>Evoke Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOK#NASDAQ">EVOK</a>) shares fell 13.4% to $3.0. The company's market cap stands at $4.4 million. </li>
<li>Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) stock declined by 13.39% to $0.53. The market value of their outstanding shares is at $2.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARAY

BJDX

BSGM

CYCC

EVOK

NCNA

NUWE

PHAT

SCNI

SXTC

VERA

12 Health Care Stocks Moving In Friday's Intraday Session

Press Releases

Correction of a Release from 05.09.2024 17:45 CET/CEST - 2CRSi SA: 2CRSi Announces the Production of its New Godì 1.8ER-NV8 Servers Equipped with 8x NVIDIA H200 SXM5 GPUs, with an Estimated Market Value of 288 million USD*

2CRSi Launches the ATLAS 1.8GG, the Densest Server in the World Designed Exclusively for Dual-phase Immersion Cooling

TCSIF

2CRSI

Comments

2CRSI

Notizie

Ultime notizie per 2CRSI (OTC:TCSIF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO